Healthy Extracts Inc.

HYEX

US42227D2099

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 12:22:40 2024-07-09 pm EDT			5-day change	1st Jan Change
3.17 ^USD	+26.80%		+26.80%	-55.97%

Jul. 09	Healthy Extracts Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2024	CI
May. 20	Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q1 Revenue $688,786	MT

Healthy Extracts Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2024

July 09, 2024 at 08:31 am EDT

Healthy Extracts Inc. provided earnings guidance for the second quarter ended June 30, 2024. Net revenue is expected to exceed a record $900,000, which would be up more than 30% from the previous quarter and up more than 50% compared to the same year-ago quarter.

Latest news about Healthy Extracts Inc.

Healthy Extracts Inc. Provides Earnings Guidance for the Second Quarter Ended June 30, 2024	Jul. 09	CI
Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q1 Revenue $688,786	May. 20	MT
Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20	CI
Healthy Extracts Inc. has withdrawn its IPO in the amount of $10.000001 million.	May. 10	CI
Healthy Extracts Inc. cancelled the acquisition of Hyperion, L.L.C. and Online Publishing & Marketing, LLC.	Apr. 17	CI
Healthy Extracts Inc. Provides Revenue Guidance for the First Quarter of 2024	Apr. 01	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Healthy Extracts Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023; Provides Revenue Guidance for the First Quarter of 2024	Mar. 13	CI
Healthy Extracts Launches First Anti-Aging Formulation, LONGEVITY	Jan. 04	CI
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Healthy Extracts Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Healthy Extracts Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Healthy Extracts Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Healthy Extracts Inc. Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Healthy Extracts Inc. announced that it expects to receive $0.3 million in funding	23-03-19	CI
Healthy Extracts Inc. has filed an IPO in the amount of $9.2 million.	23-02-09	CI
Healthy Extracts Inc. announced that it expects to receive $0.388888 million in funding	23-01-23	CI
Healthy Extracts Inc. entered into an acquisition agreement to acquire Hyperion, L.L.C. and Online Publishing & Marketing, LLC for $4.3 million..	23-01-19	CI
Healthy Extracts Inc’s Whitney Johns Launches Brain Activate ENERGY Gel Packs on WhitneyJohns.com	22-12-06	CI
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	22-11-09	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Posts Q3 EPS $0.00	22-11-09	MT
Earnings Flash (HYEX) HEALTHY EXTRACTS Reports Q3 Revenue $499.7M	22-11-09	MT
Healthy Extracts Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-08	CI
Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’S Heart Health and Overall Health Exclusively on Amazon	22-09-20	CI
Healthy Extracts Inc. Provides Revenue Guidance for the Year 2022	22-08-15	CI

Chart Healthy Extracts Inc.

Duration

Period

More charts

Company Profile

Healthy Extracts, Inc. is a platform for acquiring, developing, researching, patenting, marketing, and distributing plant-based nutraceuticals. The Company, through BergaMet NA, LLC and Ultimate Brain Nutrients, LLC markets and sells health supplemental products. Its segments include Health Supplements and Corporate. It develops, manufactures, and distributes bergamot-based products (BPF) in tablet and capsule under BergaMet Pro+, BergaMet Mega+O, BergaMet HERHEART, BergaMet Cholesterol Command, BergaMet SPORTSHEART and BergaMet CLINICAL IMMUNE. BPF Bergamet products are distributed in North America that contain Citrus Bergamot SuperFruit. Its BergaMet products are certified organic, vegan friendly, non-GMO and gluten-free. Its UBN develops plant-based health technology neuro-products to improve brain health, including memory, cognition, focus and neuro-energy. Its brain health products are sold under various product labels, including UBN ACTIVATE, UBN RELIEF, and Brain Activate-Gel.

Sector

Pharmaceuticals

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
HEALTHY EXTRACTS INC.	-55.97%	9.49M
DONG-E-E-JIAO CO.,LTD.	+14.19%	5B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-33.68%	3.52B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.74%	3.11B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.38%	2.65B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.94%	2.31B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+39.98%	1.86B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+45.87%	1.5B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-14.41%	1.41B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B